¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hypothalamic obesity with hypogonadism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® obesity ÇÑ±Û ºñ¸¸Áõ
¼³¸í   
  ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î Ã¼ÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª Ã¼Áö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â Ã¼ÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î Çؼ­ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú Ã¼Áö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³­´Ù. ºñ¸¸, Æ¯È÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, Æ¯È÷ ¼ºÀκ´À̶ó°í Çϴ ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â Ã¼ÁßÀ» ÃøÁ¤Çϴ ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡Çϴ ÀÓ»óÀûÀΠ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇϴ ¹æ¹ýÀ̸ç [½ÅÀå(cm)£­100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È­½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼Áߣ­Ç¥ÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, È¯°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼­, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù.
¿µ¹® hypogonadism ÇÑ±Û »ý½Ä»ù±â´ÉÀúÇÏÁõ
¼³¸í   
  Á¤»óÀûÀΠ³²¼º ¹× ¿©¼ºÀÌ µÇ±â À§Çؼ­´Â ½Ã»óÇϺο¡¼­ »ý½Ä»ù¹æÃâÈ£¸£¸ó, ³úÇϼöü¿¡¼­ È²Ã¼È£¸£¸ó°ú ³­Æ÷ÀÚ±ØÈ£¸£¸ó, °íȯ¿¡¼­´Â ¿À½ºÅз¯¿ò ³­¼Ò¿¡¼­´Â ¿¡½ºÆ®·Î°Õ°ú Æ÷¸£°Ô½ºÅ×·ÐÀÌ ºÐºñµÇ¾î¾ß ÇÑ´Ù. »ý½Ä»ù±â´ÉÀúÇÏÁõÀº ÀÌ·¯ÇÑ ±âÀü Áß ÀϺΰ¡ °áÇ̵ǾºÀûÀ¸·Î ¾î¸°ÀÌÀÇ »óŸ¦ ¹þ¾î³ªÁö ¸øÇÑ ¼ºÀûÀ¯Ä¡ ³»Áö ±â´É ÀúÇϵȠ°æ¿ì¸¦ ¸»ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hypogonadism
    ½Ã»óÇϺμº»ý½Ä»ùÀúÇÏÁõ, ½Ã»óÇϺμº»ý½Ä¼±ÀúÇÏÁõ
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸
  • eugonadotropic hypogonadism
    Á¤»ó»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ, Á¤»ó»ý½Ä¼±Àڱػý½Ä¼±ÀúÇÏÁõ
  • hypergonadotropic hypogonadism
    °í»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
  • hypogonadism
    »ý½Ä»ùÀúÇÏÁõ, »ý½Ä¼±ÀúÇÏÁõ
  • hypogonadotropic hypogonadism
    Àú»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ, ¼Ó¹ß»ý½Ä¼±ÀúÇÏÁõ
  • dorsal hypothalamic area
    µîÂʽûóÇϺα¸¿ª
  • hypothalamic
    ½Ã»óÇϺÎ-
  • hypothalamic inhibitory hormone
    ½Ã»óÇϺξïÁ¦È£¸£¸ó
  • hypothalamic nucleus
    ½Ã»óÇϺÎÇÙ
  • hypothalamic releasing hormone
    ½Ã»óÇϺκкñÈ£¸£¸ó
  • hypothalamic sulcus
    ½Ã»ó¾Æ·¡°í¶û, ½Ã»óÇϺÎȨ
  • hypothalamic-pituitary-adrenal axis
    ½Ã»óÇϺÎ-³úÇϼöü-ºÎ½ÅÃà
  • adult-onset obesity
    ¼ºÀιߺ´ºñ¸¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypogonadism
    »ý½Ä»ùÀúÇÏÁõ
  • hypothalamic
    ½Ã»óÇϺÎ-
  • obesity index
    ºñ¸¸Áö¼ö
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hypogonadism
    ½Ã»óÇϺλý½Ä»ùÀúÇÏÁõ
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸(Áõ)
  • eugonadotropic hypogonadism
    Á¤»ó»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
  • hypogonadism
    »ý½Ä»ùÀúÇÏÁõ
  • hypothalamic
    ½Ã»óÇϺÎ-
  • hypergonadotropic hypogonadism
    °í»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
  • hypogonadotropic hypogonadism
    Àú»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
  • hypothalamic nucleus
    ½Ã»óÇϺÎÇÙ
  • hypothalamic sulcus
    ½Ã»ó¹Ø°í¶û, ½Ã»óÇϺΰí¶û
  • hypothalamic inhibitory hormone
    ½Ã»óÇϺξïÁ¦È£¸£¸ó
  • hypothalamic releasing hormone
    ½Ã»óÇϺκкñÈ£¸£¸ó
  • postpubertal hypogonadism
    »çÃá±âÈÄ»ý½Ä»ùÀúÇÏÁõ
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ
  • alimentary obesity
    (¢¡exogenous obesity) ½Ä»çºñ¸¸
  • endogenous obesity
    ´ë»çºñ¸¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hypogonadism
    ½Ã»óÇϺμº ¼º¼±±â´ÉÀúÇÏÁõ
  • Hypothalamic obesity
    ½Ã»óÇϺκñ´ëÁõ(ÝþÓÞñø)
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • Hypogonadism
    ¼º¼±±â´ÉÀúÇÏÁõ
  • hypergonadotropic hypogonadism
    °í¼º¼±ÀÚ±ØÈ£¸£¸ó¼º ¼º¼±ºÎÀüÁõ
  • postpubertal hypogonadism
    »çÃá±âÈļº ±â´ÉÀúÇÏ(Áõ).
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(¡­ÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(ù»á÷ô÷àõ ÝþØ»ñø)
  • Hypothalamic inhibitory hormones
    ½Ã»óÇϺξïÁ¦È£¸£¸ó
  • Hypothalamic releasing hormones
    ½Ã»óÇϺκкñÈ£¸£¸ó
  • Hypothalamic-hypophysial portal system
    ½Ã»óÇϺÎ-Çϼöü ¹®¸Æ°è(ãÊßÉù»Ý» ù»á÷ô÷ Ú¦ØæÍ§)
  • anterior hypothalamic nucleus
    ¾Õ½Ã»óÇϺÎÇÙ
  • anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hypogonadism
    ½Ã»óÇϺμº ¼º¼±±â´ÉÀúÇÏÁõ
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • hypergonadotropic hypogonadism
    °í¼º¼±ÀÚ±ØÈ£¸£¸ó¼º ¼º¼±ºÎÀüÁõ
  • hypogonadism
    ¼º¼±±â´ÉÀúÇÏÁõ, ¼º¼±±â´ÉºÎÀü, Àú¼º¼±±â´ÉÁõ.
  • hypogonadotropic hypogonadism
    Àú¼º¼±ÀÚ±ØÈ£¸£¸ó¼º ¼º¼±ºÎÀüÁõ
  • male hypogonadism
    ³²¼º ¼º¼± ºÎÀüÁõ
  • postpubertal hypogonadism
    »çÃá±âÈļº ±â´ÉÀúÇÏ(Áõ).
  • postpubertal hypogonadism
    »çÃá±âÈļº ±â´ÉÀúÇÏ(Áõ)(ÞÖõðÑ¢ý­àõ ѦÒöî¸ù»(ñø))
  • secondary hypogonadism
    ¼Ó¹ß¼º ¼º¼±±â´ÉÀúÇÏ(¡­àõàÍѦÒöî¸ù»).
  • secondary hypogonadism
    ¼Ó¹ß¼º ¼º¼±±â´ÉÀúÇÏ(¡­àõàÍѦÒöî¸ù»)
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • central obesity
    Á߽ɺκñ¸¸(Áõ), ±¸°£ºñ¸¸.
  • exogenous obesity
    ¿ÜÀμº ºñ¸¸Áõ.
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • hypogonadal obesity
    ¼º±â´ÉÀúÇϼº ºñ¸¸(Áõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Posterior hypothalamic nucleus
    µÚ½Ã»óÇϺÎÇÙ
    [¿¾ ¿ë¾î] ÈĽûóÇϺÎÇÙ
  • Dorsal hypothalamic nucleus
    µîÂʽûóÇϺÎÇÙ
    [¿¾ ¿ë¾î] ¹èÃø½Ã»óÇϺÎÇÙ
  • Dorsomedial hypothalamic nucleus
    µîÂʾÈÂʽûóÇϺÎÇÙ
    [¿¾ ¿ë¾î] ¹è³»Ãø½Ã»óÇϺÎÇÙ
  • Ventromedial hypothalamic nucleus
    ¹èÂʾÈÂʽûóÇϺÎÇÙ
    [¿¾ ¿ë¾î] º¹³»Ãø½Ã»óÇϺÎÇÙ
  • Hypothalamic sulcus
    ½Ã»ó¾Æ·¡°í¶û
    [¿¾ ¿ë¾î] ½Ã»óÇϱ¸
  • Hypothalamic branch
    ½Ã»óÇϺΰ¡Áö
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁö
  • Lateral hypothalamic region
    ½Ã»óÇϺΰ¡Âʱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺοÜÃøºÎ
  • Posterior hypothalamic region
    ½Ã»óÇϺεڱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÈĺÎ
  • Dorsal hypothalamic region
    ½Ã»óÇϺεîÂʱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺιèÃøºÎ
  • Anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÀüÃøºÎ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Branches of hypothalamic nucleus
    ½Ã»óÇϺÎÇÙ°¡Áö
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÇÙÁö
  • Anterior hypothalamic nucleus
    ¾Õ½Ã»óÇϺÎÇÙ
    [¿¾ ¿ë¾î] Àü½Ã»óÇϺÎÇÙ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic hormone
    ½Ã»óÇϺÎ(ãÊßÉù»Ý») È£¸£¸ó
  • obesity
    ºñ¸¸(ÝþØ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ
  • posterior hypothalamic area
    ÈĽûóÇϺοµ¿ª
  • obesity
    ºñ¸¸(Áõ)
  • pituitary obesity
    Çϼöü¼ººñ¸¸Áõ
  • truncal obesity
    Á߽ɼººñ¸¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IHH idiopathic hypogonadotropic hypogonadism; idiopathic hypothalamic hypogonadism; infectious human hep...
HHHO hypotonia, hypomentia, hypogonadism, obesity [syndrome]
CHARGE Associations   Coloboma
  Heart disease
  Atresia choanae
  Reta...
AADH alopecia-anosmia-deafness-hypogonadism [syndrome]
AHH alpha-hydrazine analog of histidine; anosmia and hypogonadotropic hypogonadism [syndrome]; arylhydro...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DIO Diet-induced obesity
OHS Obesity Hypoventilation Syndrome
%OB obesity
HHG Hypogonadotrophic hypogonadism
HH Hypogonadotropic Hypogonadism
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hypogonadotropic hypogonadism
    Àú¼º¼± ÀÚ±Ø È£¸£¸ó¼º ¼º¼± ºÎÀüÁõ
  • adrenocortical obesity
    ºÎ½Å ÇÇÁú¼º ºñ¸¸, ºÎ½Å ÇÇÁú¼º ºñ¸¸Áõ
  • hypogonadal obesity
    ¼º ±â´É ÀúÇϼº ºñ¸¸, ¼º ±â´É ÀúÇϼº ºñ¸¸Áõ
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
    1. ½Åü¿¡ Áö¹æÀÇ °úµµÇÑ ÃàÀûÀ¸·Î °ñ°Ý°ú À°Ã¼ÀÇ ¿ä±¸ ÇѰ踦 ³Ñ¾î¼­¼­ ¸ö¹«°Ô°¡ Áõ°¡ÇÏ´Â °Í. 2. Áö¹æ Á¶Á÷ÀÇ ´ë»ç Àå¾Ö¿¡ ÀÇÇÏ¿© Áö¹æÀÇ ¿¬¼Ò°¡ ºÒÃæºÐÇÏ°Ô µÇ¾î ½ÅüÀÇ ¿©·¯ °÷¿¡ Áö¹æÀÇ ÀÌ»ó Ä§ÂøÀÌ ÀϾ´Â Áõ¼¼. Áö¹æ °ú´ÙÁõÀ̶ó°íµµ ÇÑ´Ù. ´ë°³´Â ³»ºÐºñ¼±ÀÇ ÀÌ»ó, ¶Ç´Â ³»ºÐºñ¼± »óÈ£°£ÀÇ ÀÌ»ó¿¡ ±âÀÎÇÑ´Ù. ¿¹¸¦ µé¸é, ¼º¼±¼º ºñ¸¸º´, °©»ó¼± ±â´É ÀúÇϳª, ºÎ½Å ÇÇÁú ±â´É Ç×Áø, Çϼöü °£³ú°è Àå¾Ö¿¡ ÀÇÇÑ ºñ¸¸ÁõÀÌ ÀÖÀ¸¸ç, À̵éÀ» ³»Àμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. À̰Ϳ¡ ´ëÇØ °úµµÀÇ ¿µ¾ç ¼·Ãë·Î ÀÎÇÑ °ÍÀ» ¿ÜÀμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. 3. ÈçÇÑ ¹®Á¦À̳ª Áõ¸íÇÒ ¸¸ÇÑ ³»ºÐºñÀû ¿øÀÎÀº µå¹°¸ç, ÈçÈ÷ ´Ù¸¥ ¿øÀο¡ ÀÇÇÑ´Ù. ½ÅüÀû Ȱµ¿ ÀúÇÏ¿¡ ÀÇÇØ¼­ ¾à°£ÀÇ Ã¼Áß Áõ°¡°¡ À¯¹ßµÇ¸ç ³ëÈ­µµ ºñ¸¸Áõ¿¡ ¿ªÇÒÀ» ÇÑ´Ù. Áï 20¼¼¿¡¼­ 63¼¼ »çÀÌÀÇ ¼ºÀο¡¼­´Â ¿¬°£ 0.1kg/§³ÀÇ Ã¼Áß Áõ°¡°¡ ÀÖ´Ù. À¯ÀüÀº °¡Àå Áß¿äÇÑ ºñ¸¸ÁõÀÇ °áÁ¤ ÀÎÀÚÀÌ´Ù. ½ÖµÕÀÌ ¿¬±¸¿¡ ÀÇÇÏ¸é ºñ¸¸ÁõÀÇ 70%´Â À¯ÀüÀû ÀÎÀÚ¿¡ ÀÇÇÑ´Ù´Â °ÍÀÌ ½Ã»çµÇ¾ú´Ù. ºñ¸¸ÁõÀ» Á¶ÀýÇÏ´Â À¯Àü ÀÎÀÚ
  • paradoxical obesity
    ±âÀÌ ºñ¸¸Áõ
  • truncal obesity
    Á߽ɼº ºñ¸¸
  • dorsal hypothalamic nucleus
    µîÂÊ ½Ã»ó ÇϺΠÇÙ
  • dorsomedial hypothalamic nucleus
    µîÂÊ ¾ÈÂÊ ½Ã»ó ÇϺΠÇÙ
  • hypothalamic beta-endorphin neuron
    ½Ã»ó ÇϺÎÀÇ º£Å¸-¿£µ¹ÇÉ ´º¿ì·±
  • hypothalamic center
    ½Ã»ó ÇϺΠÁßÃß
  • hypothalamic diabetic insipidus
    ½Ã»ó ÇϺμº ¿äºØÁõ
  • hypothalamic hormone
    ½Ã»ó ÇϺΠȣ¸£¸ó
  • hypothalamic hypophysiotropic hormone
    ½Ã»ó ÇϺμº Çâ³úÇϼöü¼º È£¸£¸ó
  • hypothalamic osmoreceptor
    ½Ã»ó ÇϺΠ»ïÅõ ¼ö¿ë±â
  • hypothalamic pituitary gonadal axis
    ½Ã»ó ÇϺΠ³úÇϼöü ¼º¼±°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
hypothalamic obesity with hypogonadism A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
male hypogonadism A state in which testes are present but fail to function normally; may be of gonadal or pituitary origin.
Synonym: eunuchism, male hypogonadism.
Hypergonadotropic eunuchoidism, eunuchoidism of gonadal origin, commonly accompanied by enhanced levels of pituitary gonadotropins in the blood and urine, as in Klinefelter's syndrome.
(05 Mar 2000)
primary hypogonadism Defective gonadal development or function, or both, due to abnormality or loss of the gonad itself.
(05 Mar 2000)
secondary hypogonadism Defective gonadal development or function, or both, resulting from inadequate secretion of pituitary gonadotropins.
Synonym: hypogonadotropic eunuchoidism, secondary hypogonadism.
(05 Mar 2000)
hypergonadotropic hypogonadism Defective gonadal development or function of the gonads, resulting from elevated levels of gonadotropins.
(05 Mar 2000)
hypogonadism <endocrinology> A condition resulting from or characterised by abnormally decreased functional activity of the gonads, with retardation of growth and sexual development.
(18 Nov 1997)
hypogonadism with anosmia Failure of sexual development secondary to inadequate secretion of pituitary gonadotropins, associated with anosmia due to agenesis of the olfactory lobes of the brain; probably X-linked inheritance.
Synonym: Kallmann's syndrome.
(05 Mar 2000)
hypogonadotropic hypogonadism Defective gonadal development or function, or both, resulting from inadequate secretion of pituitary gonadotropins.
Synonym: hypogonadotropic eunuchoidism, secondary hypogonadism.
(05 Mar 2000)
familial hypogonadotropic hypogonadism A group of disorders characterised by failure of sexual development, owing to inadequate secretion of pituitary gonadotropins; perhaps X-linked or autosomal recessive inheritance.
(05 Mar 2000)
anti-obesity agents Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity.
(12 Dec 1998)
central obesity The deposition of obesity around the trunk sparing the limbs.
(27 Sep 1997)
risks, obesity-related Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness)
(12 Dec 1998)
morbid obesity Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition.
Simple obesity, obesity resulting when caloric intake exceeds energy expenditure.
(05 Mar 2000)
diseases, obesity-related Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness).
(12 Dec 1998)
obesity <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body.
Origin: L. Obesus = fat
(18 Nov 1997)
obesity index Body weight divided by body volume.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸;ºñ´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á